XML 40 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
¥ in Thousands, $ in Thousands
Ordinary shares
Adjusted balance after adjustment for change in accounting standard
CNY (¥)
shares
Ordinary shares
IPO
CNY (¥)
shares
Ordinary shares
Follow-on public offering
CNY (¥)
shares
Ordinary shares
CNY (¥)
shares
Treasury shares
CNY (¥)
shares
Additional paid-In capital
Adjusted balance after adjustment for change in accounting standard
CNY (¥)
Additional paid-In capital
IPO
CNY (¥)
Additional paid-In capital
Follow-on public offering
CNY (¥)
Additional paid-In capital
CNY (¥)
Statutory reserves
Adjusted balance after adjustment for change in accounting standard
CNY (¥)
Statutory reserves
CNY (¥)
Accumulated other comprehensive income (loss)
Adjusted balance after adjustment for change in accounting standard
CNY (¥)
Accumulated other comprehensive income (loss)
CNY (¥)
Accumulated deficit
Adjusted balance after adjustment for change in accounting standard
CNY (¥)
Accumulated deficit
Adjustment for change in accounting standard
CNY (¥)
Accumulated deficit
CNY (¥)
Attributable to owners of KE Holdings Inc.
Adjusted balance after adjustment for change in accounting standard
CNY (¥)
Attributable to owners of KE Holdings Inc.
Adjustment for change in accounting standard
CNY (¥)
Attributable to owners of KE Holdings Inc.
IPO
CNY (¥)
Attributable to owners of KE Holdings Inc.
Follow-on public offering
CNY (¥)
Attributable to owners of KE Holdings Inc.
CNY (¥)
Non-controlling interests
Adjusted balance after adjustment for change in accounting standard
CNY (¥)
Non-controlling interests
CNY (¥)
Adjusted balance after adjustment for change in accounting standard
CNY (¥)
Adjustment for change in accounting standard
CNY (¥)
IPO
CNY (¥)
Follow-on public offering
CNY (¥)
CNY (¥)
shares
USD ($)
shares
Beginning balance at Dec. 31, 2019 ¥ 202     ¥ 202   ¥ 2,533,889     ¥ 2,533,889 ¥ 253,732 ¥ 253,732 ¥ 63,308 ¥ 63,308 ¥ (11,866,154) ¥ (90,517) ¥ (11,775,637) ¥ (9,015,023) ¥ (90,517)     ¥ (8,924,506) ¥ 87,203 ¥ 87,203 ¥ (8,927,820) ¥ (90,517)     ¥ (8,837,303)  
Beginning balance (in shares) at Dec. 31, 2019 | shares 1,470,166,690     1,470,166,690                                                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                          
Net income (loss)                               2,777,592         2,777,592   731         ¥ 2,778,323  
Exercise of share options (in shares) | shares                                                       0 0
Issuance of ordinary shares   ¥ 51 ¥ 16 ¥ 3     ¥ 16,345,771 ¥ 15,284,267 605,392                   ¥ 16,345,822 ¥ 15,284,283 605,395         ¥ 16,345,822 ¥ 15,284,283 ¥ 605,395  
Issuance of ordinary shares (in shares) | shares   365,700,000 122,130,000 22,652,050                                                  
Share-based compensation                 2,252,589                       2,252,589             2,252,589  
Accretion on convertible redeemable preferred shares to redemption value                 (1,755,228)                       (1,755,228)             (1,755,228)  
Automatic conversion of preferred shares into ordinary shares upon initial public offering ("IPO")       ¥ 210         42,127,913                       42,128,123             42,128,123  
Automatic conversion of preferred shares into ordinary shares upon initial public offering ("IPO") (in shares) | shares       1,510,766,620                                                  
Ordinary shares issuance upon IPO, net of issuance costs                                                       16,345,822  
Appropriation to statutory reserves                     139,102         (139,102)                       (139,100)  
Currency translation adjustments                         (1,897,395)               (1,897,395)             (1,897,395)  
Acquisition of non-controlling interests                 39,289                       39,289   (60,865)         (21,576)  
Ending balance at Dec. 31, 2020       ¥ 482         77,433,882   392,834   (1,834,087)     (9,227,664)         66,765,447   27,069         66,792,516  
Ending balance (in shares) at Dec. 31, 2020 | shares       3,491,415,360                                                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                          
Net income (loss)                               (524,129)         (524,129)   (637)         (524,766)  
Exercise of share options       ¥ 7                                 7             ¥ 7  
Exercise of share options (in shares) | shares       57,076,970                                               57,076,970 57,076,970
Share-based compensation                 1,538,287                       1,538,287             ¥ 1,538,287  
Appropriation to statutory reserves                     91,053         (91,053)                       (91,100)  
Currency translation adjustments                         (841,214)               (841,214)             (841,214)  
Acquisition of a subsidiary with noncontrolling interests                                             55,085         55,085  
Unrealized gains on available-for-sale investments, net of reclassification                         45,242               45,242             45,242  
Unrealized gains on available-for-sale investments, amounts reclassified from accumulated other comprehensive income                         (9,664)               (9,664)             (9,664)  
Ending balance at Dec. 31, 2021       ¥ 489         78,972,169   483,887   (2,639,723)     (9,842,846)         66,973,976   81,517         67,055,493  
Ending balance (in shares) at Dec. 31, 2021 | shares       3,548,492,330                                                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                          
Net income (loss)                               (1,386,074)         (1,386,074)   (11,210)         (1,397,284) $ (202,586)
Exercise of share options       ¥ 3                                 3             ¥ 3  
Exercise of share options (in shares) | shares       24,383,373                                               24,383,373 24,383,373
Vesting of restricted share units (in shares) | shares       576,720                                                  
Share-based compensation                 2,425,249                       2,425,249             ¥ 2,425,249  
Cancellation of ordinary shares       ¥ (5) ¥ 1,094,467       (1,094,462)                                        
Cancellation of ordinary shares (in shares) | shares       (35,246,628) 35,246,628                                                
Repurchase of ordinary shares         ¥ (1,319,796)                               (1,319,796)             (1,319,796)  
Repurchase of ordinary shares (in shares) | shares         (41,707,914)                                                
Appropriation to statutory reserves                     176,930         (176,930)                       (176,900)  
Currency translation adjustments                         2,602,071               2,602,071             2,602,071 $ 377,265
Acquisition of a subsidiary with noncontrolling interests                                             63,771         63,771  
Unrealized gains on available-for-sale investments, net of reclassification                         (470,589)               (470,589)             (470,589)  
Unrealized gains on available-for-sale investments, amounts reclassified from accumulated other comprehensive income                         95,520               95,520             95,520  
Ending balance at Dec. 31, 2022       ¥ 487         ¥ 80,302,956   ¥ 660,817   ¥ (412,721)     ¥ (11,405,850)         ¥ 68,920,360   ¥ 134,078         69,054,438 10,011,951
Ending balance (in shares) at Dec. 31, 2022 | shares       3,538,205,792                                                  
Treasury shares, ending balance at Dec. 31, 2022         ¥ (225,329)                                             ¥ 225,329 $ 32,670
Treasury shares, ending balance (in shares) at Dec. 31, 2022 | shares         (6,461,286)                                                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                          
Surrender of ordinary shares (in shares) | shares       (3)